|
"Development of Generic Trastuzmab for the Treatment of Breast Cancer."
|
N44CO120045-000
|
$2,499,488
|
$2,499,488
|
LESZCZYNIECKA, MAGDALENA
|
STC BIOLOGICS, INC.
|
|
"RNAi Synthetic Lethal Screen in Cancer Cell Models."
|
N44CO120065-000
|
$999,596
|
$339,863
|
CHENCHIK, ALEXANDR
|
CELLECTA, INC.
|
|
"Target Specific and Drug Loaded Iron Oxide Nanoparticles for Cancer Imaging and
|
N44CO120029-000
|
$1,200,000
|
$1,200,000
|
WANG, ANDREW
|
OCEAN NANO TECH LLC
|
|
13C DIM REPRESSES ANDROGEN-INDUCED TWIST 1 EXPRESSION IN HUMAN PROSTATE CANCER
|
Y01CN129005
|
$68,000
|
$34,000
|
UNKNOWN, UNKNOWN
|
U.S. NATIONAL INSTITUTES OF HEALTH
|
|
2010 Mammary Gland Biology GRC
|
5R13CA150225-03
|
$5,000
|
$5,000
|
JERRY, D
|
GORDON RESEARCH CONFERENCES
|
|
3-D Computer Modeling for Optimizing Body Image following Breast Reconstruction
|
5R01CA143190-03
|
$574,081
|
$574,081
|
Markey, Mia
|
UNIVERSITY OF TEXAS AUSTIN
|
|
3-D quantitative microwave breast imaging system for comparison with MRI
|
5R21CA161369-02
|
$189,373
|
$189,373
|
HAGNESS, SUSAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
3D Digital Breast Phantoms For Multimodality Research
|
5R01CA134658-03
|
$319,872
|
$319,872
|
Segars, William
|
DUKE UNIVERSITY
|
|
3D Optical Imaging and Digital Xray of Breast Lesions
|
5R01CA097305-09
|
$348,490
|
$348,490
|
Boas, David
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
3D Photoacoustic Tomography (PAT)and Dynamic Contrast-Enhanced PAT Breast Imaging
|
1R01CA160850-01A1
|
$654,145
|
$654,145
|
KRUGER, ROBERT
|
OPTOSONICS, INC.
|
|
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
|
1R01CA169182-01
|
$341,852
|
$341,852
|
GANESAN, SHRIDAR
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
A Cancer Rainbow Mouse for the Simultaneous Assessment of Multiple Oncogenes
|
1R21CA173245-01
|
$235,546
|
$77,730
|
Caron, Marc
|
DUKE UNIVERSITY
|
|
A comprehensive approach to breast cancer susceptibility across the risk spectrum
|
5R01CA155767-02
|
$544,870
|
$544,870
|
Goldgar, David
|
UNIVERSITY OF UTAH
|
|
A Cyber-Informatics Approach to Studying Migration and Environmental Cancer Risk
|
1R01CA170508-01
|
$410,454
|
$205,227
|
Tourassi, Georgia
|
UT-BATTELLE, LLC-OAK RIDGE NATIONAL LAB
|
|
A Fluorescence Histology System for In Vivo Breast Tumor Margin Assessment
|
5R21CA159936-02
|
$132,750
|
$132,750
|
BROWN, JONATHAN
|
DUKE UNIVERSITY
|
|
A Fluorescence Histology System for In Vivo Breast Tumor Margin Assessment
|
7R21CA159936-03
|
$123,466
|
$123,466
|
BROWN, JONATHAN
|
TULANE UNIVERSITY OF LOUISIANA
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
1UM1CA164974-01A1
|
$2,196,670
|
$439,334
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-19
|
$1,716,455
|
$858,228
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans
|
1U01CA158428-01A1
|
$342,475
|
$171,238
|
Buckhaults, Phillip
|
GEORGIA HEALTH SCIENCES UNIVERSITY
|
|
A genome-wide association study for breast cancer in BRCA1 mutation carriers
|
5R01CA128978-05
|
$667,287
|
$667,287
|
Couch, Fergus
|
MAYO CLINIC
|
|
A HER-2/neu pulsed DC1 vaccine for patients with DCIS
|
5R01CA096997-07
|
$497,125
|
$497,125
|
CZERNIECKI, BRIAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
3R01CA072038-15S1
|
$49,685
|
$49,685
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
5R01CA072038-15
|
$291,192
|
$291,192
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-06
|
$374,097
|
$56,115
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A novel biomarker and therapeutic target for breast cancer
|
5R21CA157168-02
|
$173,456
|
$173,456
|
SHEIKH, M
|
UPSTATE MEDICAL UNIVERSITY
|
|
A NOVEL BREAST CANCER BIOMARKER
|
5R01CA112021-08
|
$303,610
|
$303,610
|
SGROI, DENNIS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A Novel Dose Calculation Method for Targeted Radionuclide Therapy
|
7R01CA138986-03
|
$327,806
|
$163,903
|
MOURTADA, FIRAS
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
A novel function of TIMP-1
|
5R01CA089113-10
|
$261,358
|
$261,358
|
KIM, HYEONG-REH
|
WAYNE STATE UNIVERSITY
|
|
A novel growth regulatory factor in breast cells
|
5R01CA092440-10
|
$290,758
|
$290,758
|
MONTANO, MONICA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Novel Mechanism of PI3K Membrane Docking Promotes Lapatinib Resistance
|
1F31CA165819-01A1
|
$28,584
|
$28,584
|
Brady, Samuel
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A novel method for quantitation of fragmented mRNAs (mR-FQ)
|
1R43CA159743-01A1
|
$300,000
|
$300,000
|
KAZAKOV, SERGEI
|
SOMAGENICS, INC.
|
|
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
|
2R44CA139841-02A1
|
$633,309
|
$158,327
|
PRABHAKARPANDIAN, BALABHASKAR
|
CFD RESEARCH CORPORATION
|
|
A novel model system for risk assessment of BRCA carriers
|
1F31CA168180-01
|
$42,232
|
$42,232
|
Cochran, Rory
|
JOHNS HOPKINS UNIVERSITY
|
|
A Novel Plasminogen Receptor in Breast Cancer
|
1R01CA166473-01
|
$464,971
|
$464,971
|
MUELLER, BARBARA
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors
|
5R21CA158877-02
|
$156,527
|
$156,527
|
LEPORE, STEPHEN
|
TEMPLE UNIVERSITY
|
|
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials
|
2R44CA144362-02A1
|
$689,294
|
$172,324
|
Wiener, Matthew
|
PHARMATECH, INC.
|
|
A program of immune-based treatments for cancer
|
5K24CA093670-10
|
$182,272
|
$91,136
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
A RCT TO PROMOTE MAMMOGRAPHY ADHERENCE AMONG CHINESE IMMIGRANT WOMEN
|
5R01CA142941-03
|
$604,713
|
$604,713
|
WANG, JUDY
|
GEORGETOWN UNIVERSITY
|
|
A Role for the Novel Poly(A) RNA-Binding Protein, ZC3H14, in Breast Cancer
|
1F31CA168321-01
|
$30,912
|
$30,912
|
Wigington, Callie
|
EMORY UNIVERSITY
|
|
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
|
5R01CA155432-02
|
$351,713
|
$351,713
|
Mulder, Willem
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
A Systems Approach To Iron Metabolism In Cancer Cells
|
5R21CA156133-02
|
$201,615
|
$201,615
|
LAUBENBACHER, REINHARD
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-14
|
$759,738
|
$151,948
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
A university-industry partnership for improving the imaging performance of digita
|
5R01CA148053-03
|
$388,531
|
$388,531
|
ZHAO, WEI
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
A Viral Cytokine as a Promoter of Tumor Progression
|
3R15CA158767-01S1
|
$79,902
|
$79,902
|
SPENCER, JULIET
|
UNIVERSITY OF SAN FRANCISCO
|
|
A Web Tutor to Help Women Decide About Testing for Genetic Breast Cancer Risk
|
5R21CA149796-02
|
$161,733
|
$161,733
|
Wolfe, Christopher
|
MIAMI UNIVERSITY OXFORD
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-03S1
|
$33,534
|
$8,384
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-03S2
|
$50,001
|
$12,500
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-03S3
|
$119,786
|
$29,947
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
5U54CA153499-03
|
$968,834
|
$242,209
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
$62,924
|
Sinha, Rashmi
|
DCEG (NCI)
|
Total relevant funding to Breast for this search: $602,728,719
|